Rome, Italy

Mario Bigioni

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2003-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Mario Bigioni

Introduction

Mario Bigioni is a prominent inventor based in Rome, Italy. He has made significant contributions to the fields of immunology and molecular biology. With a total of 4 patents to his name, his work focuses on developing pharmaceutical combinations that target specific cancer-related pathways.

Latest Patents

Among his latest patents, one notable invention is a pharmaceutical combination comprising an anti-LY75 antibody. This patent relates to the development of pharmaceutical combinations that include antibodies directed against LY75, along with a second anti-cancer entity. Another significant patent involves pharmaceutical combinations that include antibodies against LY75 and Venetoclax, aimed at treating diseases mediated by LY75 expression or activity.

Career Highlights

Mario Bigioni has worked with reputable companies in the pharmaceutical industry, including Berlin-Chemie AG and Menarini Ricerche S.p.A. His experience in these organizations has allowed him to contribute to groundbreaking research and development in cancer treatment.

Collaborations

Throughout his career, Mario has collaborated with esteemed colleagues such as Giuseppe Merlino and Monica Binaschi. These partnerships have further enhanced his research and innovation in the field.

Conclusion

Mario Bigioni's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His patents and collaborations continue to pave the way for advancements in cancer treatment and immunology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…